Analyst Consensus
- Current Price
- 184.29 $
- Target (Low)
- 155.00 $
- Target (Mean)
- 252.64 $
- Target (High)
- 400.00 $
- Recommendation
- Buy
- Number of Analysts
- 39
Recommendation Distribution
Recommendation Distribution| Strong Buy | 6 |
|---|
| Buy | 30 |
|---|
| Hold | 6 |
|---|
| Sell | 1 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 25.4%
- Operating Margin
- 36.3%
- Gross Margin
- 65.8%
- Return on Equity (ROE)
- 53.4%
- Return on Assets (ROA)
- 6.5%
- Revenue Growth
- 20.6%
- Earnings Growth
- 21.9%
- Debt/Equity
- 362.76
- Current Ratio
- 1.12
- Beta
- 1.66
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 11, 2026 | Bernstein | Outperform → Outperform |
| Jun 11, 2026 | RBC Capital | Sector Perform → Sector Perform |
| Jun 11, 2026 | TD Cowen | Buy → Buy |
| Jun 11, 2026 | Barclays | Overweight → Overweight |
| Jun 11, 2026 | Cantor Fitzgerald | Overweight → Overweight |
| Jun 11, 2026 | Wedbush | Outperform → Outperform |